Pledge to optimise the transition from paediatric to adult care in sickle cell disease
Thank you for committing your support to driving health system change to ensure an optimal transition for every young person with sickle cell disease, regardless of where they live.
When you submit this form, the details you provide will be shared with MHP Group as Secretariat of the Sickle Cell Transitions Policy Lab. In line with GDPR laws, MHP Group will not share your details with anyone, but may reach out to you occasionally with updates on the work of the Policy Lab. If you do not wish to be contacted, please select ‘no’ in the final question below.
We are grateful to Novo Nordisk and Pfizer for commissioning and funding the Charter and this website.
